What they were paid
Viridian Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | — | $0 | — | $0 | — |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Viridian Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-160344, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Viridian Therapeutics pays directors a $40,000 cash retainer and $201,402 in equity.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair) · Science
The rest of the Viridian Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Arlene M. Morris | Independent Director | $271,402 |
| Jeff Ajer | Independent Director | $598,246 |
| Jennifer K. Moses | Independent Director | $268,902 |
| Sarah Gheuens | Independent Director | $248,902 |
| Stephen Mahoney | Director | $0 |
| Tomas Kiselak | Chair of the Board | $293,902 |
The full Viridian Therapeutics compensation record
free company briefThis page is one director within Viridian Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat